GLR Partners »

Immunitybio shares owned by GLR Partners

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by GLR Partners from 13F filings

Historical chart of GLR Partners investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by GLR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by GLR Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $153k 20k 7.67

More positions owned by GLR Partners

Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Series Trust State Street Spd (BIL)
Wisdomtree Tr Us Quality Grow (QGRW)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Spdr Gold Tr Gold Shs (GLD)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYG)
Pacer Fds Tr Trendp Us Lar Cp (PTLC)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)

View all positions for GLR Partners

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio